Here you go: unless I am reading this wrong, which talks

New Post Public Reply Private Reply Replies (1) Message Board
hylander rjs9787 #9673
215
Here you go: unless I am reading this wrong, which talks about the registered offering from the S1.

That's 40 million, and then if we can get--we believe the investment bank will raise additional capital to that. We get those monies in, then I start turning
on... we go from the pieces of the companies that we acquire with little or no money--which is pretty amazing--to actually putting those resources--money resources--into those very businesses to build huge value. And to build a full- on enterprise--we can't do that without money, and it's amazing what we've done with not a lot of money.
So, we've acquired the pieces, we're now going to raise the money next year-- like I said all along, to get that going concern off, which is one more piece in NASDAQ listing prong, getting that going concern off. And then putting those dollars into those pieces that we've acquired to build a very, very large enterprise.
So, it's sold out. And you can't build it without money and raising the kind of money from a registered offering is the only way to go.
Allen: So, the 40 million that you speak about, is that from funds that have committed to participate in this offering? I'm not really sure about that 40
million pieces of it.
Joe: We have definitive documents for $40 million in equity. That will give us enough capital over the next two or three years to build everything we need.
We're not going to stop there--the goal is 70, we believe we can get there. I would like to see the share price go up a little bit more.
But I will say we will file the S-1 immediately--hopefully, by the end of next week. And then we can add to it if we're able to get one of the other interested funds that requires the S-1 to be filed to invest.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Updated Category News Views 58

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 109

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
Guidewire's 2026 Awards Highlight AI in Insurance Shift

Updated Category News Views 44

AI Takes Center Stage at Guidewire's Annual Gala Change is constant, but when it comes with a potent mix of AI and insurance, you know things are about to get interesting. Guidewire Software (NYSE: GWRE) is tipping its hat to Beazley, Definity, and RCIS, the standouts at its annual Innovation Awards. Held during their CONNECTIONS Conference in Las Vegas, this year's...

Continue Reading
UPM's WISA Group Demerger: A Strategic Shift

Updated Category News Views 136

UPM's Bold Move on the Chessboard In a market that's no stranger to seismic tremors, UPM's decision to move forward with the partial demerger of its Kymmene Corporation is something that raises a few eyebrows. But hey, isn't shaking things up half the fun in this business? The Finnish Financial Supervisory Authority giving a thumbs-up to the supplement listing for WISA...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 152

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
United Imaging Surges with 19.43% Revenue Growth in 2026

Updated Category News Views 0

United Imaging's Remarkable Revenue Surge Coming out of Shanghai, we've got some major numbers to chew on. United Imaging Healthcare (688271.SH)—this isn't your run-of-the-mill medical tech firm—is bringing some serious heat to the market with a 19.43% bump in revenue. We're talking RMB 10.58 billion raked in over just the first nine months of 2026. Those are hefty...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 73

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 65

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
MGM China Hits Record Highs Amid Market Challenges

Updated Category News Views 59

Highs Amid Headwinds: MGM China's Standout Quarter Rolling into one's portfolio, MGM China isn't just coasting along—it's smashing some records, despite fierce headwinds. It's not all smooth sailing in Macau's gaming scene, but MGM China has hammered out its third-quarter results with gusto, setting new records for revenue and adjusted EBITDA. These folks aren't just...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 206

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
=2">More News Articles